Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2023 08:00 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Issues Letter to Shareholders

GAITHERSBURG, Md., Dec. 29, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
December 06, 2023 07:00 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity

The market for obesity drugs is projected to exceed $77 billion by 2030 Dr. Randy Seeley, a recognized expert on novel treatments for obesity, to lead study GAITHERSBURG, Md., Dec. 06, 2023 ...
October 18, 2023 09:00 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI to Present at Benzinga All Access Event on October 20

GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
October 05, 2023 08:00 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

Discoveries generated by analyzing The Cancer Genome Atlas using proprietary bfLEAP™ platform Target validation will be conducted through partnership with J. Craig Venter Institute (JCVI), a...
September 26, 2023 08:00 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma

GAITHERSBURG, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using...
September 25, 2023 08:00 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using...
September 20, 2023 08:00 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform

GAITHERSBURG, Md., Sept. 20, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
September 14, 2023 16:30 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at Maxim Group’s Emerging Growth in AI Virtual Tech Conference Series

GAITHERSBURG, Md., Sept. 14, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using...
September 13, 2023 07:01 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development

GAITHERSBURG, Md., Sept. 13, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...
September 07, 2023 16:05 ET | Source: BullFrog AI Holdings, Inc.

BullFrog AI Announces Investor Webinar with CEO and Founder Vin Singh on Thursday, September 14, 2023

GAITHERSBURG, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using...